Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
2016 · Blood · 1,512 citations
https://doi.org/10.1182/blood-2016-01-690636
C
Carlos Rodríguez‐Galindo
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
726
Papers
27.5K
Citations
87
h-index
304
i10-index
Carlos Rodríguez‐Galindo is an academic researcher from St. Jude Children's Research Hospital. The author has contributed to research in topics: Childhood Cancer Survivors' Quality of Life & Ocular Oncology and Treatments & Neuroblastoma Research and Treatments. The author has an h-index of 87, co-authored 618 publications.
ORCID: 0000-0002-2360-8946Papers by this author
worksConsensus recommendations for the diagnosis and clinical management of Rosai-Dorfman-Destombes disease
2018 · Blood · 584 citations
https://doi.org/10.1182/blood-2018-03-839753
Comparing Adult and Pediatric Rhabdomyosarcoma in the Surveillance, Epidemiology and End Results Program, 1973 to 2005: An Analysis of 2,600 Patients
2009 · Journal of Clinical Oncology · 469 citations
https://doi.org/10.1200/jco.2008.19.7483
Challenges in the diagnosis of hemophagocytic lymphohistiocytosis: Recommendations from the North American Consortium for Histiocytosis (NACHO)
2019 · Pediatric Blood & Cancer · 404 citations
https://doi.org/10.1002/pbc.27929
Clinicopathologic Features and Long-term Outcomes of NUT Midline Carcinoma
2012 · Clinical Cancer Research · 397 citations
https://doi.org/10.1158/1078-0432.ccr-12-1153
The global burden of childhood and adolescent cancer in 2017: an analysis of the Global Burden of Disease Study 2017
2019 · The Lancet Oncology · 386 citations
https://doi.org/10.1016/s1470-2045(19)30339-0
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat